Literature DB >> 16131655

Aggregation of granulocyte-colony stimulating factor in vitro involves a conformationally altered monomeric state.

Stephen W Raso1, Jeff Abel, Jesse M Barnes, Kevin M Maloney, Gary Pipes, Michael J Treuheit, Jonathan King, David N Brems.   

Abstract

Aggregation of partially folded intermediates populated during protein folding processes has been described for many proteins. Likewise, partially unfolded chains, generated by perturbation of numerous proteins by heat or chemical denaturants, have also been shown to aggregate readily. However, the process of protein aggregation from native-state conditions is less well understood. Granulocyte-colony stimulating factor (G-CSF), a member of the four-helix bundle class of cytokines, is a therapeutically relevant protein involved in stimulating the growth and maturation of phagocytotic white blood cells. Under native-like conditions (37 degrees C [pH 7.0]), G-CSF shows a significant propensity to aggregate. Our data suggest that under these conditions, native G-CSF exists in equilibrium with an altered conformation, which is highly aggregation prone. This species is enriched in 1-2 M GdmCl, as determined by tryptophan fluorescence and increased aggregation kinetics. In particular, specific changes in Trp58 fluorescence report a local rearrangement in the large loop region between helices A and B. However, circular dichroism, reactivity toward cyanylation, and ANS binding demonstrate that this conformational change is subtle, having no substantial disruption of secondary and tertiary structure, reactivity of the free sulfhydryl at Cys17 or exposure of buried hydrophobic regions. There is no indication that this altered conformation is important to biological activity, making it an attractive target for rational protein stabilization.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16131655      PMCID: PMC2253479          DOI: 10.1110/ps.051489405

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  53 in total

Review 1.  Protein refolding for industrial processes.

Authors:  E D Clark
Journal:  Curr Opin Biotechnol       Date:  2001-04       Impact factor: 9.740

Review 2.  There's a right way and a wrong way: in vivo and in vitro folding, misfolding and subunit assembly of the P22 tailspike.

Authors:  S Betts; J King
Journal:  Structure       Date:  1999-06-15       Impact factor: 5.006

3.  Inhibition of stress-induced aggregation of protein therapeutics.

Authors:  J F Carpenter; B S Kendrick; B S Chang; M C Manning; T W Randolph
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

4.  Aggregation events occur prior to stable intermediate formation during refolding of interleukin 1beta.

Authors:  J M Finke; M Roy; B H Zimm; P A Jennings
Journal:  Biochemistry       Date:  2000-01-25       Impact factor: 3.162

5.  Inhibiting transthyretin conformational changes that lead to amyloid fibril formation.

Authors:  S A Peterson; T Klabunde; H A Lashuel; H Purkey; J C Sacchettini; J W Kelly
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

6.  Recombinant human granulocyte colony-stimulating factor: effects on normal and leukemic myeloid cells.

Authors:  L M Souza; T C Boone; J Gabrilove; P H Lai; K M Zsebo; D C Murdock; V R Chazin; J Bruszewski; H Lu; K K Chen; J Barendt; E Platzer; M A S Moore; R Mertelsmann; K Welte
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

7.  Analysis of protein aggregation kinetics.

Authors:  F Ferrone
Journal:  Methods Enzymol       Date:  1999       Impact factor: 1.600

8.  Reengineering granulocyte colony-stimulating factor for enhanced stability.

Authors:  B Bishop; D C Koay; A C Sartorelli; L Regan
Journal:  J Biol Chem       Date:  2001-06-13       Impact factor: 5.157

9.  Atomic structure of the GCSF-receptor complex showing a new cytokine-receptor recognition scheme.

Authors:  M Aritomi; N Kunishima; T Okamoto; R Kuroki; Y Ota; K Morikawa
Journal:  Nature       Date:  1999-10-14       Impact factor: 49.962

10.  Aggregation of granulocyte colony stimulating factor under physiological conditions: characterization and thermodynamic inhibition.

Authors:  Sampathkumar Krishnan; Eva Y Chi; Jonathan N Webb; Byeong S Chang; Daxian Shan; Merrill Goldenberg; Mark C Manning; Theodore W Randolph; John F Carpenter
Journal:  Biochemistry       Date:  2002-05-21       Impact factor: 3.162

View more
  24 in total

1.  EGCG induces G-CSF expression and neutrophilia in experimental sepsis.

Authors:  Wei Li; Andrew H Wu; Shu Zhu; Jianhua Li; Rong Wu; John D'Angelo; Haichao Wang
Journal:  Immunol Res       Date:  2015-12       Impact factor: 2.829

2.  Protein structural conformation and not second virial coefficient relates to long-term irreversible aggregation of a monoclonal antibody and ovalbumin in solution.

Authors:  Harminder Bajaj; Vikas K Sharma; Advait Badkar; David Zeng; Sandeep Nema; Devendra S Kalonia
Journal:  Pharm Res       Date:  2006-05-25       Impact factor: 4.200

Review 3.  Oxidation of therapeutic proteins and peptides: structural and biological consequences.

Authors:  Riccardo Torosantucci; Christian Schöneich; Wim Jiskoot
Journal:  Pharm Res       Date:  2013-09-25       Impact factor: 4.200

4.  Glycosylation of Therapeutic Proteins: A Critical Quality Attribute.

Authors:  Arnaud Delobel
Journal:  Methods Mol Biol       Date:  2021

5.  Biochemical and biophysical characterization of cytokine-like protein 1 (CYTL1).

Authors:  Aurelie Tomczak; Kavita Singh; Apostolos G Gittis; Joohee Lee; David N Garboczi; Philip M Murphy
Journal:  Cytokine       Date:  2017-05-04       Impact factor: 3.861

6.  Nonspecific shielding of unfavorable electrostatic intramolecular interactions in the erythropoietin native-state increase conformational stability and limit non-native aggregation.

Authors:  Douglas D Banks
Journal:  Protein Sci       Date:  2015-04-11       Impact factor: 6.725

7.  Determination of Critical Quality Attributes for a Biotherapeutic in the QbD Paradigm: GCSF as a Case Study.

Authors:  Sumit K Singh; Deepak Kumar; Anurag S Rathore
Journal:  AAPS J       Date:  2017-09-05       Impact factor: 4.009

8.  Fully Synthetic Granulocyte Colony-Stimulating Factor Enabled by Isonitrile-Mediated Coupling of Large, Side-Chain-Unprotected Peptides.

Authors:  Andrew G Roberts; Eric V Johnston; Jae-Hung Shieh; Joseph P Sondey; Ronald C Hendrickson; Malcolm A S Moore; Samuel J Danishefsky
Journal:  J Am Chem Soc       Date:  2015-10-01       Impact factor: 15.419

9.  Genetic selection for enhanced folding in vivo targets the Cys14-Cys38 disulfide bond in bovine pancreatic trypsin inhibitor.

Authors:  Linda Foit; Antje Mueller-Schickert; Bharath S Mamathambika; Stefan Gleiter; Caitlyn L Klaska; Guoping Ren; James C A Bardwell
Journal:  Antioxid Redox Signal       Date:  2011-01-23       Impact factor: 8.401

Review 10.  Effects of glycosylation on the stability of protein pharmaceuticals.

Authors:  Ricardo J Solá; Kai Griebenow
Journal:  J Pharm Sci       Date:  2009-04       Impact factor: 3.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.